Literature DB >> 16136550

Iontophoretic transdermal delivery of sumatriptan: effect of current density and ionic strength.

A Femenía-Font1, C Balaguer-Fernández, V Merino, A López-Castellano.   

Abstract

Iontophoretic transdermal delivery of sumatriptan was investigated in vitro. Among the conditions tested, 0.25 mA/cm2 and low ionic strength (NaCl 25 mM) was the best experimental condition to increase its transport across the skin. The flux increased 385-fold respective to passive diffusion, thus resulting in a transdermal flux of sumatriptan of 1273+/-83 nmol/cm2 h. Copyright (c) 2005 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16136550     DOI: 10.1002/jps.20447

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

Review 1.  Transdermal delivery of sumatriptan for the treatment of acute migraine.

Authors:  Mark W Pierce
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.